학술논문

Serum CXCL5 as a biomarker in multiple sclerosis and neuromyelitis optica spectrum disorder.
Document Type
Article
Source
Northern Clinics of Istanbul; 2023, Vol. 10 Issue 3, p341-344, 4p
Subject
NEUROMYELITIS optica
BIOMARKERS
BLOOD serum analysis
MULTIPLE sclerosis
SPINAL cord diseases
Language
ISSN
21484902
Abstract
Copyright of Northern Clinics of Istanbul is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)